Results 221 to 230 of about 75,945 (317)

Integrating Surface Normal Vectors Using Fast Marching Method

open access: bronze, 2006
Jeffrey Ho   +3 more
openalex   +1 more source

Fostering Urban Climate Transition Through Innovative Governance Coordination

open access: yesEnvironmental Policy and Governance, EarlyView.
ABSTRACT The role of cities in addressing the challenge of climate change is growing and becoming more noticeable in global debates and actions on the ground. However, transformative innovations needed for addressing complex and wicked societal challenges cannot be achieved by cities alone and require concerted efforts also at national and ...
Kateryna Pereverza   +2 more
wiley   +1 more source

The outcomes of electronic personal health records in patients with heart failure or coronary artery disease

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1464-1468, April 2025.
Abstract Background There are limited data on the efficacy of smartphone‐based personal health records (PHRs) in patients with cardiovascular disease. This study aimed to examine the processes, outcomes and challenges associated with the implementation of integrated PHRs in patients with heart failure (HF) or coronary artery disease (CAD). Methods This
Kotaro Nochioka   +16 more
wiley   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk   +12 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Interactive visualization of large molecular systems with VTX: example with a minimal whole-cell model. [PDF]

open access: yesFront Bioinform
Maria M   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy